{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:50:43Z","timestamp":1787068243031,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2003159"],"award-info":[{"award-number":["2003159"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2003756"],"award-info":[{"award-number":["2003756"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1154325"],"award-info":[{"award-number":["1154325"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1113577"],"award-info":[{"award-number":["1113577"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["208694\/Z\/17\/Z"],"award-info":[{"award-number":["208694\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008717","name":"Sylvia and Charles Viertel Charitable Foundation","doi-asserted-by":"publisher","award":["VTL2016F027"],"award-info":[{"award-number":["VTL2016F027"]}],"id":[{"id":"10.13039\/100008717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012789","name":"Veski","doi-asserted-by":"publisher","award":["VIF 14"],"award-info":[{"award-number":["VIF 14"]}],"id":[{"id":"10.13039\/100012789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SCHU 3126\/ 3-1"],"award-info":[{"award-number":["SCHU 3126\/ 3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"EC | European Regional Development Fund","doi-asserted-by":"publisher","award":["PID2021-125106OB-C31"],"award-info":[{"award-number":["PID2021-125106OB-C31"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Missense mutations in\n                    <jats:italic>PLCG2<\/jats:italic>\n                    can cause autoinflammation with phospholipase C gamma 2-associated antibody deficiency and immune dysregulation (APLAID). Here, we generated a mouse model carrying an APLAID mutation (p.Ser707Tyr) and found that inflammatory infiltrates in the skin and lungs were only partially ameliorated by removing inflammasome function via the deletion of caspase-1. Also, deleting interleukin-6 or tumor necrosis factor did not fully prevent APLAID mutant mice from autoinflammation. Overall, these findings are in accordance with the poor response individuals with APLAID have to treatments that block interleukin-1, JAK1\/2 or tumor necrosis factor. Cytokine analysis revealed increased granulocyte colony-stimulating factor (G-CSF) levels as the most distinct feature in mice and individuals with APLAID. Remarkably, treatment with a G-CSF antibody completely reversed established disease in APLAID mice. Furthermore, excessive myelopoiesis was normalized and lymphocyte numbers rebounded. APLAID mice were also fully rescued by bone marrow transplantation from healthy donors, associated with reduced G-CSF production, predominantly from non-hematopoietic cells. In summary, we identify APLAID as a G-CSF-driven autoinflammatory disease, for which targeted therapy is feasible.\n                  <\/jats:p>","DOI":"10.1038\/s41590-023-01473-6","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T07:12:19Z","timestamp":1680592339000},"page":"814-826","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["G-CSF drives autoinflammation in APLAID"],"prefix":"10.1038","volume":"24","author":[{"given":"Elisabeth","family":"Mulazzani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4757-504X","authenticated-orcid":false,"given":"Juan I.","family":"Ar\u00f3stegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9690-0879","authenticated-orcid":false,"given":"Ashley P.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishika","family":"Ranathunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3110-8984","authenticated-orcid":false,"given":"Waruni","family":"Abeysekera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra L.","family":"Garnham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze-Ling","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6396-2739","authenticated-orcid":false,"given":"Jacob T.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Lich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret L.","family":"Hibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7050-6822","authenticated-orcid":false,"given":"Ian P.","family":"Wicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8382-6358","authenticated-orcid":false,"given":"Cynthia","family":"Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4763-576X","authenticated-orcid":false,"given":"Seth L.","family":"Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,30]]},"reference":[{"key":"1473_CR1","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.ajhg.2012.08.006","volume":"91","author":"Q Zhou","year":"2012","unstructured":"Zhou, Q. et al. A hypermorphic missense mutation in PLCG2, encoding phospholipase C\u03b32, causes a dominantly inherited autoinflammatory disease with immunodeficiency. Am. J. Hum. Genet. 91, 713\u2013720 (2012).","journal-title":"Am. J. Hum. Genet."},{"key":"1473_CR2","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.3389\/fimmu.2018.02863","volume":"9","author":"JF Neves","year":"2018","unstructured":"Neves, J. F. et al. Novel PLCG2 mutation in a patient with APLAID and cutis laxa. Front. Immunol. 9, 2863 (2018).","journal-title":"Front. Immunol."},{"key":"1473_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10875-019-00731-3","volume":"40","author":"T Novice","year":"2020","unstructured":"Novice, T. et al. A germline mutation in the C2 domain of PLC\u03b32-associated with gain-of-function expands the phenotype for PLCG2-related diseases. J. Clin. Immunol. 40, 267\u2013276 (2020).","journal-title":"J. Clin. Immunol."},{"key":"1473_CR4","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1111\/jdv.15918","volume":"33","author":"E Moran-Villasenor","year":"2019","unstructured":"Moran-Villasenor, E. et al. Expanding the clinical features of autoinflammation and phospholipase C\u03b32-associated antibody deficiency and immune dysregulation by description of a novel patient. J. Eur. Acad. Dermatol. Venereol. 33, 2334\u20132339 (2019).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"1473_CR5","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s10875-020-00794-7","volume":"40","author":"A Martin-Nalda","year":"2020","unstructured":"Martin-Nalda, A. et al. Severe autoinflammatory manifestations and antibody deficiency due to novel hypermorphic PLCG2 mutations. J. Clin. Immunol. 40, 987\u20131000 (2020).","journal-title":"J. Clin. Immunol."},{"key":"1473_CR6","doi-asserted-by":"publisher","first-page":"104387","DOI":"10.1016\/j.ejmg.2021.104387","volume":"65","author":"HS Park","year":"2022","unstructured":"Park, H. S. et al. A novel likely pathogenic PLCG2 variant in a patient with a recurrent skin blistering disease and B cell lymphopenia. Eur. J. Med. Genet. 65, 104387 (2022).","journal-title":"Eur. J. Med. Genet."},{"key":"1473_CR7","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1056\/NEJMoa1102140","volume":"366","author":"MJ Ombrello","year":"2012","unstructured":"Ombrello, M. J. et al. Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. N. Engl. J. Med. 366, 330\u2013338 (2012).","journal-title":"N. Engl. J. Med."},{"key":"1473_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11589","volume":"7","author":"JA Burger","year":"2016","unstructured":"Burger, J. A. et al. Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition. Nat. Commun. 7, 11589 (2016).","journal-title":"Nat. Commun."},{"key":"1473_CR9","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/ng.3916","volume":"49","author":"R Sims","year":"2017","unstructured":"Sims, R. et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer\u2019s disease. Nat. Genet. 49, 1373\u20131384 (2017).","journal-title":"Nat. Genet."},{"key":"1473_CR10","doi-asserted-by":"publisher","first-page":"102607","DOI":"10.1016\/j.ebiom.2019.102607","volume":"51","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Structural insights and activating mutations in diverse pathologies define mechanisms of deregulation for phospholipase C gamma enzymes. EBioMedicine 51, 102607 (2020).","journal-title":"EBioMedicine"},{"key":"1473_CR11","doi-asserted-by":"publisher","first-page":"9986","DOI":"10.1128\/MCB.24.22.9986-9999.2004","volume":"24","author":"YJ Kim","year":"2004","unstructured":"Kim, Y. J., Sekiya, F., Poulin, B., Bae, Y. S. & Rhee, S. G. Mechanism of B cell receptor-induced phosphorylation and activation of phospholipase C-\u03b32. Mol. Cell. Biol. 24, 9986\u20139999 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"1473_CR12","doi-asserted-by":"publisher","first-page":"5660","DOI":"10.1073\/pnas.89.12.5660","volume":"89","author":"KM Coggeshall","year":"1992","unstructured":"Coggeshall, K. M., McHugh, J. C. & Altman, A. Predominant expression and activation-induced tyrosine phosphorylation of phospholipase C-\u03b32 in B lymphocytes. Proc. Natl Acad. Sci. USA 89, 5660\u20135664 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1473_CR13","doi-asserted-by":"publisher","first-page":"100905","DOI":"10.1016\/j.jbc.2021.100905","volume":"297","author":"JT Jackson","year":"2021","unstructured":"Jackson, J. T., Mulazzani, E., Nutt, S. L. & Masters, S. L. The role of PLC\u03b32 in immunological disorders, cancer, and neurodegeneration. J. Biol. Chem. 297, 100905 (2021).","journal-title":"J. Biol. Chem."},{"key":"1473_CR14","doi-asserted-by":"publisher","first-page":"23083","DOI":"10.1074\/jbc.M109.019265","volume":"284","author":"KL Everett","year":"2009","unstructured":"Everett, K. L. et al. Characterization of phospholipase C gamma enzymes with gain-of-function mutations. J. Biol. Chem. 284, 23083\u201323093 (2009).","journal-title":"J. Biol. Chem."},{"key":"1473_CR15","doi-asserted-by":"publisher","first-page":"5354","DOI":"10.4049\/jimmunol.1301326","volume":"191","author":"M Engelke","year":"2013","unstructured":"Engelke, M. et al. Cutting edge: feed-forward activation of phospholipase C\u03b32 via C2 domain-mediated binding to SLP65. J. Immunol. 191, 5354\u20135358 (2013).","journal-title":"J. Immunol."},{"key":"1473_CR16","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1080\/15548627.2015.1034406","volume":"11","author":"S Obba","year":"2015","unstructured":"Obba, S. et al. The PRKAA1\/AMPK\u03b11 pathway triggers autophagy during CSF1-induced human monocyte differentiation and is a potential target in CMML. Autophagy 11, 1114\u20131129 (2015).","journal-title":"Autophagy"},{"key":"1473_CR17","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1002\/jcp.22507","volume":"226","author":"CM Leon","year":"2011","unstructured":"Leon, C. M. et al. Requirement for PLC\u03b32 in IL-3 and GM-CSF-stimulated MEK\/ERK phosphorylation in murine and human hematopoietic stem\/progenitor cells. J. Cell. Physiol. 226, 1780\u20131792 (2011).","journal-title":"J. Cell. Physiol."},{"key":"1473_CR18","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/art.38961","volume":"67","author":"JJ Chae","year":"2015","unstructured":"Chae, J. J. et al. Connecting two pathways through Ca2+ signaling: NLRP3 inflammasome activation induced by a hypermorphic PLCG2 mutation. Arthritis Rheumatol. 67, 563\u2013567 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"1473_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.immuni.2005.01.018","volume":"22","author":"P Yu","year":"2005","unstructured":"Yu, P. et al. Autoimmunity and inflammation due to a gain-of-function mutation in phospholipase C\u03b32 that specifically increases external Ca2+ entry. Immunity 22, 451\u2013465 (2005).","journal-title":"Immunity"},{"key":"1473_CR20","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1002\/art.30280","volume":"63","author":"K Abe","year":"2011","unstructured":"Abe, K. et al. A novel N-ethyl-N-nitrosourea-induced mutation in phospholipase C\u03b32 causes inflammatory arthritis, metabolic defects, and male infertility in vitro in a murine model. Arthritis Rheum. 63, 1301\u20131311 (2011).","journal-title":"Arthritis Rheum."},{"key":"1473_CR21","doi-asserted-by":"publisher","first-page":"117793222091330","DOI":"10.1177\/1177932220913307","volume":"14","author":"LM Avila-Portillo","year":"2020","unstructured":"Avila-Portillo, L. M. et al. Comparative analysis of the biosimilar and innovative G-CSF modulated pathways on umbilical cord blood-derived mononuclear cells. Bioinform. Biol. Insights 14, 1177932220913307 (2020).","journal-title":"Bioinform. Biol. Insights"},{"key":"1473_CR22","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1136\/annrheumdis-2012-202857","volume":"73","author":"M Zong","year":"2014","unstructured":"Zong, M. et al. Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers: a mechanistic study with 12 months follow-up. Ann. Rheum. Dis. 73, 913\u2013920 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"1473_CR23","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/ni852","volume":"3","author":"M Merad","year":"2002","unstructured":"Merad, M. et al. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 3, 1135\u20131141 (2002).","journal-title":"Nat. Immunol."},{"key":"1473_CR24","doi-asserted-by":"publisher","first-page":"11398","DOI":"10.1073\/pnas.0404328101","volume":"101","author":"KE Lawlor","year":"2004","unstructured":"Lawlor, K. E. et al. Critical role for granulocyte colony-stimulating factor in inflammatory arthritis. Proc. Natl Acad. Sci. USA 101, 11398\u201311403 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1473_CR25","doi-asserted-by":"publisher","first-page":"4392","DOI":"10.4049\/jimmunol.1600121","volume":"197","author":"IK Campbell","year":"2016","unstructured":"Campbell, I. K. et al. Therapeutic targeting of the G-CSF receptor reduces neutrophil trafficking and joint inflammation in antibody-mediated inflammatory arthritis. J. Immunol. 197, 4392\u20134402 (2016).","journal-title":"J. Immunol."},{"key":"1473_CR26","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ajpath.2015.09.008","volume":"186","author":"GL Goldberg","year":"2016","unstructured":"Goldberg, G. L. et al. G-CSF and neutrophils are nonredundant mediators of murine experimental autoimmune uveoretinitis. Am. J. Pathol. 186, 172\u2013184 (2016).","journal-title":"Am. J. Pathol."},{"key":"1473_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1084\/jem.20141015","volume":"212","author":"JM Rumble","year":"2015","unstructured":"Rumble, J. M. et al. Neutrophil-related factors as biomarkers in EAE and MS. J. Exp. Med. 212, 23\u201335 (2015).","journal-title":"J. Exp. Med."},{"key":"1473_CR28","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1182\/blood-2015-02-629444","volume":"125","author":"RB Day","year":"2015","unstructured":"Day, R. B., Bhattacharya, D., Nagasawa, T. & Link, D. C. Granulocyte colony-stimulating factor reprograms bone marrow stromal cells to actively suppress B lymphopoiesis in mice. Blood 125, 3114\u20133117 (2015).","journal-title":"Blood"},{"key":"1473_CR29","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/337471a0","volume":"337","author":"F Bussolino","year":"1989","unstructured":"Bussolino, F. et al. Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 337, 471\u2013473 (1989).","journal-title":"Nature"},{"key":"1473_CR30","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1182\/blood.V99.5.1863.h8001863_1863_1865","volume":"99","author":"S Suzuki","year":"2002","unstructured":"Suzuki, S. et al. Autocrine production of epithelial cell-derived neutrophil attractant-78 induced by granulocyte colony-stimulating factor in neutrophils. Blood 99, 1863\u20131865 (2002).","journal-title":"Blood"},{"key":"1473_CR31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/sj.bmt.1701552","volume":"23","author":"N Sugimori","year":"1999","unstructured":"Sugimori, N. et al. Administration of G\u2212CSF to normal individuals diminishes L-selectin+ T cells in the peripheral blood that respond better to alloantigen stimulation than L-selectin- T cells. Bone Marrow Transplant. 23, 119\u2013124 (1999).","journal-title":"Bone Marrow Transplant."},{"key":"1473_CR32","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s002620000158","volume":"49","author":"A Fattorossi","year":"2001","unstructured":"Fattorossi, A. et al. Effects of granulocyte colony-stimulating factor and granulocyte\/macrophage colony-stimulating factor administration on T cell proliferation and phagocyte cell-surface molecules during hematopoietic reconstitution after autologous peripheral blood progenitor cell transplantation. Cancer Immunol. Immunother. 49, 641\u2013648 (2001).","journal-title":"Cancer Immunol. Immunother."},{"key":"1473_CR33","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1046\/j.1365-2567.1998.00529.x","volume":"94","author":"LE Bermudez","year":"1998","unstructured":"Bermudez, L. E., Petrofsky, M. & Stevens, P. Treatment with recombinant granulocyte colony-stimulating factor (Filgrastin) stimulates neutrophils and tissue macrophages and induces an effective non-specific response against Mycobacterium avium in mice. Immunology 94, 297\u2013303 (1998).","journal-title":"Immunology"},{"key":"1473_CR34","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1182\/blood-2002-07-2132","volume":"101","author":"A Villunger","year":"2003","unstructured":"Villunger, A., Scott, C., Bouillet, P. & Strasser, A. Essential role for the BH3-only protein Bim but redundant roles for Bax, Bcl-2 and Bcl-w in the control of granulocyte survival. Blood 101, 2393\u20132400 (2003).","journal-title":"Blood"},{"key":"1473_CR35","doi-asserted-by":"publisher","first-page":"4172","DOI":"10.4049\/jimmunol.167.8.4172","volume":"167","author":"RJ Benschop","year":"2001","unstructured":"Benschop, R. J., Brandl, E., Chan, A. C. & Cambier, J. C. Unique signaling properties of B cell antigen receptor in mature and immature B cells: implications for tolerance and activation. J. Immunol. 167, 4172\u20134179 (2001).","journal-title":"J. Immunol."},{"key":"1473_CR36","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.4049\/jimmunol.174.5.2687","volume":"174","author":"ME Moreno-Garcia","year":"2005","unstructured":"Moreno-Garcia, M. E. et al. CD38 signaling regulates B lymphocyte activation via a phospholipase C (PLC)-\u03b32-independent, protein kinase C, phosphatidylcholine-PLC, and phospholipase D-dependent signaling cascade. J. Immunol. 174, 2687\u20132695 (2005).","journal-title":"J. Immunol."},{"key":"1473_CR37","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.imbio.2010.09.016","volume":"216","author":"H Ying","year":"2011","unstructured":"Ying, H., Li, Z., Yang, L. & Zhang, J. Syk mediates BCR- and CD40-signaling integration during B cell activation. Immunobiology 216, 566\u2013570 (2011).","journal-title":"Immunobiology"},{"key":"1473_CR38","doi-asserted-by":"publisher","first-page":"5957","DOI":"10.1128\/MCB.02273-06","volume":"27","author":"L Bai","year":"2007","unstructured":"Bai, L. et al. Phospholipase C\u03b32 contributes to light-chain gene activation and receptor editing. Mol. Cell. Biol. 27, 5957\u20135967 (2007).","journal-title":"Mol. Cell. Biol."},{"key":"1473_CR39","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.4049\/jimmunol.178.3.1405","volume":"178","author":"DJ de Gorter","year":"2007","unstructured":"de Gorter, D. J., Vos, J. C., Pals, S. T. & Spaargaren, M. The B cell antigen receptor controls AP-1 and NFAT activity through Ras-mediated activation of Ral. J. Immunol. 178, 1405\u20131414 (2007).","journal-title":"J. Immunol."},{"key":"1473_CR40","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S1074-7613(00)80269-1","volume":"5","author":"JH Wang","year":"1996","unstructured":"Wang, J. H. et al. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 5, 537\u2013549 (1996).","journal-title":"Immunity"},{"key":"1473_CR41","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1172\/JCI27514","volume":"116","author":"C Cataisson","year":"2006","unstructured":"Cataisson, C. et al. CXCR2 ligands and G-CSF mediate PKC\u03b1-induced intraepidermal inflammation. J. Clin. Invest. 116, 2757\u20132766 (2006).","journal-title":"J. Clin. Invest."},{"key":"1473_CR42","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1002\/art.41704","volume":"73","author":"K Futosi","year":"2021","unstructured":"Futosi, K., Kasa, O., Szilveszter, K. P. & Mocsai, A. Neutrophil phospholipase C\u03b32 drives autoantibody-induced arthritis through the generation of the inflammatory microenvironment. Arthritis Rheumatol. 73, 1614\u20131625 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"1473_CR43","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1002\/eji.201546185","volume":"46","author":"AD Christensen","year":"2016","unstructured":"Christensen, A. D., Haase, C., Cook, A. D. & Hamilton, J. A. Granulocyte colony-stimulating factor (G-CSF) plays an important role in immune complex-mediated arthritis. Eur. J. Immunol. 46, 1235\u20131245 (2016).","journal-title":"Eur. J. Immunol."},{"key":"1473_CR44","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1365-2141.1991.tb04375.x","volume":"78","author":"E Vellenga","year":"1991","unstructured":"Vellenga, E., van der Vinne, B., De Wolf, J. T. & Halie, M. R. Simultaneous expression and regulation of G-CSF and IL-6 mRNA in adherent human monocytes and fibroblasts. Br. J. Haematol. 78, 14\u201318 (1991).","journal-title":"Br. J. Haematol."},{"key":"1473_CR45","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/75973","volume":"25","author":"CI Rodriguez","year":"2000","unstructured":"Rodriguez, C. I. et al. High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat. Genet. 25, 139\u2013140 (2000).","journal-title":"Nat. Genet."},{"key":"1473_CR46","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/368339a0","volume":"368","author":"M Kopf","year":"1994","unstructured":"Kopf, M. et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368, 339\u2013342 (1994).","journal-title":"Nature"},{"key":"1473_CR47","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2337\/diabetes.53.1.99","volume":"53","author":"WH Schott","year":"2004","unstructured":"Schott, W. H. et al. Caspase-1 is not required for type 1 diabetes in the NOD mouse. Diabetes 53, 99\u2013104 (2004).","journal-title":"Diabetes"},{"key":"1473_CR48","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1002\/eji.1830270822","volume":"27","author":"H Korner","year":"1997","unstructured":"Korner, H., Lemckert, F. A., Chaudhri, G., Etteldorf, S. & Sedgwick, J. D. Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system. Eur. J. Immunol. 27, 1973\u20131981 (1997).","journal-title":"Eur. J. Immunol."},{"key":"1473_CR49","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1182\/blood.V84.6.1737.1737","volume":"84","author":"GJ Lieschke","year":"1994","unstructured":"Lieschke, G. J. et al. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84, 1737\u20131746 (1994).","journal-title":"Blood"},{"key":"1473_CR50","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.4049\/jimmunol.168.10.4827","volume":"168","author":"KS Schluns","year":"2002","unstructured":"Schluns, K. S., Williams, K., Ma, A., Zheng, X. X. & Lefrancois, L. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J. Immunol. 168, 4827\u20134831 (2002).","journal-title":"J. Immunol."},{"key":"1473_CR51","doi-asserted-by":"publisher","first-page":"e20191421","DOI":"10.1084\/jem.20191421","volume":"217","author":"C Louis","year":"2020","unstructured":"Louis, C. et al. NK cell-derived GM-CSF potentiates inflammatory arthritis and is negatively regulated by CIS. J. Exp. Med. 217, e20191421 (2020).","journal-title":"J. Exp. Med."},{"key":"1473_CR52","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkz114","volume":"47","author":"Y Liao","year":"2019","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. Nucleic Acids Res. 47, e47 (2019).","journal-title":"Nucleic Acids Res."},{"key":"1473_CR53","first-page":"1438","volume":"5","author":"Y Chen","year":"2016","unstructured":"Chen, Y., Lun, A. T. & Smyth, G. K. From reads to genes to pathways: differential expression analysis of RNA-seq experiments using Rsubread and the edgeR quasi-likelihood pipeline. F1000Res 5, 1438 (2016).","journal-title":"F1000Res"},{"key":"1473_CR54","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"1473_CR55","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S1046-2023(03)00155-5","volume":"31","author":"GK Smyth","year":"2003","unstructured":"Smyth, G. K. & Speed, T. Normalization of cDNA microarray data. Methods 31, 265\u2013273 (2003).","journal-title":"Methods"},{"key":"1473_CR56","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/1471-2105-7-261","volume":"7","author":"ME Ritchie","year":"2006","unstructured":"Ritchie, M. E. et al. Empirical array quality weights in the analysis of microarray data. BMC Bioinformatics 7, 261 (2006).","journal-title":"BMC Bioinformatics"},{"key":"1473_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).","journal-title":"Genome Biol."},{"key":"1473_CR58","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1214\/16-AOAS920","volume":"10","author":"B Phipson","year":"2016","unstructured":"Phipson, B., Lee, S., Majewski, I. J., Alexander, W. S. & Smyth, G. K. Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression. Ann. Appl. Stat. 10, 946\u2013963 (2016).","journal-title":"Ann. Appl. Stat."},{"key":"1473_CR59","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1093\/bioinformatics\/bti270","volume":"21","author":"GK Smyth","year":"2005","unstructured":"Smyth, G. K., Michaud, J. & Scott, H. S. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21, 2067\u20132075 (2005).","journal-title":"Bioinformatics"},{"key":"1473_CR60","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1093\/bioinformatics\/btq401","volume":"26","author":"D Wu","year":"2010","unstructured":"Wu, D. et al. ROAST: rotation gene-set tests for complex microarray experiments. Bioinformatics 26, 2176\u20132182 (2010).","journal-title":"Bioinformatics"},{"key":"1473_CR61","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.immuni.2009.05.005","volume":"30","author":"SD Brydges","year":"2009","unstructured":"Brydges, S. D. et al. Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity. Immunity 30, 875\u2013887 (2009).","journal-title":"Immunity"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-023-01473-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-023-01473-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-023-01473-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T11:08:47Z","timestamp":1683025727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-023-01473-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,30]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["1473"],"URL":"https:\/\/doi.org\/10.1038\/s41590-023-01473-6","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,30]]},"assertion":[{"value":"3 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.L.M. is a Scientific Advisor for Odyssey Therapeutics and NRG Therapeutics. S.-L.N. and J.N. are employees of GSK. I.P.W. has acted as a Scientific Advisor for CSL and received funding for research on G-CSF antagonism in inflammatory diseases. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}